Cogent Biosciences Inc (NASDAQ:COGT)
| 9.63 BATS BZX Real-Time Price As of 2:27pm ET |  -0.05 / -0.52%Today’s Change | 9.48 Today|||52-Week Range 15.68 | -16.70% Year-to-Date |
Latest COGT News | Press Releases
No recent news for Cogent Biosciences Inc.
Today’s Trading
| Previous close | 9.68 |
| Today’s open | 9.79 |
| Day’s range | 9.48 - 9.80 |
| Volume | 9,880 |
| Average volume (3 months) | 757,735 |
| Market cap | $855.9M |
Data as of 2:27pm ET, 09/27/2023
Growth & Valuation
| Earnings growth (last year) | -27.95% |
| Earnings growth (this year) | +9.76% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.69 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BCYCBicycle Therapeutics... | +0.18 | +0.90% |
| ---- | ||
| ADMAADMA Biologics Inc | +0.00 | +0.14% |
| RGNXRegenxbio Inc | +0.36 | +2.10% |
Data as of 2:27pm ET, 09/27/2023
Financials
| Next reporting date | November 13, 2023 |
| EPS forecast (this quarter) | -$0.54 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$140.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
